About Index Trending news
Analyze
Pricing
Aerie Pharmaceuticals

Aerie Pharmaceuticals

Work at Aerie Pharmaceuticals? Add yourself to this profile

Aerie Pharmaceuticals

Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Undisclosed
$40,000,000
Novartis Venture Fund, OrbiMed, Kearny Venture Partners, +3
Post-IPO equity
$125,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$40,000,000 Undisclosed
PE Hub

Aerio Pharmaceuticals takes in about $40 mln

Funding Messaging
$125,000,000 Post-IPO equity
businesswire

Aerie Pharmaceuticals Raises $125 Million in Public Offerings | Business Wire

The Motley Fool

Why Safety Data Is Sending Aerie Pharmaceuticals Soaring Today

Stock markets